Literature DB >> 18818942

Primary splenic diffuse large B-cell lymphoma manifesting in red pulp.

Makoto Kashimura1, Masahiro Noro, Bunshiro Akikusa, Atsushi Okuhara, Shuji Momose, Ikuo Miura, Masaru Kojima, Jun-Ichi Tamaru.   

Abstract

We evaluated six cases of diffuse large B-cell lymphoma (DLBCL) involving the red pulp of the spleen. All had B symptoms and an aggressive clinical course. The lymphoma cells proliferated diffusely and non-cohesively in the cords of the red pulp. The lymphoma involved the bone marrow in four of the five patients and the liver in all four of the patients examined. However, lymph node (LN) involvement was rare at presentation, and systemic LN involvement was not observed even in the terminal phase. The lymphoma cells infiltrated the intrasinusoidal/intravascular and interstitial spaces of the involved tissues and were detected in the peripheral blood in two of the six patients. CD5-expressing lymphoma cells were detected in four of the five patients examined. Because these cases had some unique clinical features and occurred in distinct splenic sites, we proposed that primary splenic DLBCL manifesting in red pulp is a distinct clinicopathological entity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18818942     DOI: 10.1007/s00428-008-0673-y

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  39 in total

Review 1.  Splenic marginal zone lymphoma.

Authors:  Vito Franco; Ada Maria Florena; Emilio Iannitto
Journal:  Blood       Date:  2002-11-21       Impact factor: 22.113

2.  Splenic marginal zone lymphoma with or without villous lymphocytes. Hematologic findings and outcomes in a series of 57 patients.

Authors:  Emilio Iannitto; Achille Ambrosetti; Emanuele Ammatuna; Maura Colosio; Ada M Florena; Claudio Tripodo; Viviana Minardi; Giuseppina Calvaruso; Maria Enza Mitra; Giovanni Pizzolo; Fabio Menestrina; Vito Franco
Journal:  Cancer       Date:  2004-11-01       Impact factor: 6.860

3.  Non-MALT marginal zone B-cell lymphomas: a description of clinical presentation and outcome in 124 patients.

Authors:  F Berger; P Felman; C Thieblemont; T Pradier; L Baseggio; P A Bryon; G Salles; E Callet-Bauchu; B Coiffier
Journal:  Blood       Date:  2000-03-15       Impact factor: 22.113

4.  Splenic involvement by aggressive malignant lymphomas of B-cell and T-cell types. A morphologic and immunophenotypic study.

Authors:  R M Stroup; J S Burke; K Sheibani; J Ben-Ezra; M Brownell; C D Winberg
Journal:  Cancer       Date:  1992-01-15       Impact factor: 6.860

5.  Definition, diagnosis, and management of intravascular large B-cell lymphoma: proposals and perspectives from an international consensus meeting.

Authors:  Maurilio Ponzoni; Andrés J M Ferreri; Elías Campo; Fabio Facchetti; Luca Mazzucchelli; Tadashi Yoshino; Takuhei Murase; Stefano A Pileri; Claudio Doglioni; Emanuele Zucca; Franco Cavalli; Shigeo Nakamura
Journal:  J Clin Oncol       Date:  2007-06-18       Impact factor: 44.544

6.  De novo CD5+ diffuse large B-cell lymphoma: a clinicopathologic study of 109 patients.

Authors:  Motoko Yamaguchi; Masao Seto; Masataka Okamoto; Ryo Ichinohasama; Naoya Nakamura; Tadashi Yoshino; Junji Suzumiya; Takuhei Murase; Ikuo Miura; Takashi Akasaka; Jun-ichi Tamaru; Ritsuro Suzuki; Yoshitoyo Kagami; Masami Hirano; Yasuo Morishima; Ryuzo Ueda; Hiroshi Shiku; Shigeo Nakamura
Journal:  Blood       Date:  2002-02-01       Impact factor: 22.113

7.  Trisomy 3 in marginal zone B-cell lymphoma: a study based on cytogenetic analysis and fluorescence in situ hybridization.

Authors:  J Dierlamm; L Michaux; I Wlodarska; S Pittaluga; W Zeller; M Stul; A Criel; J Thomas; M Boogaerts; P Delaere; J J Cassiman; C de Wolf-Peeters; C Mecucci; H Van den Berghe
Journal:  Br J Haematol       Date:  1996-04       Impact factor: 6.998

8.  Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray.

Authors:  Christine P Hans; Dennis D Weisenburger; Timothy C Greiner; Randy D Gascoyne; Jan Delabie; German Ott; H Konrad Müller-Hermelink; Elias Campo; Rita M Braziel; Elaine S Jaffe; Zenggang Pan; Pedro Farinha; Lynette M Smith; Brunangelo Falini; Alison H Banham; Andreas Rosenwald; Louis M Staudt; Joseph M Connors; James O Armitage; Wing C Chan
Journal:  Blood       Date:  2003-09-22       Impact factor: 22.113

9.  De novo CD5+ diffuse large B-cell lymphoma: results of a detailed clinicopathological review in 120 patients.

Authors:  Motoko Yamaguchi; Naoya Nakamura; Ritsuro Suzuki; Yoshitoyo Kagami; Masataka Okamoto; Ryo Ichinohasama; Tadashi Yoshino; Junji Suzumiya; Takuhei Murase; Ikuo Miura; Koichi Ohshima; Momoko Nishikori; Jun-ichi Tamaru; Masafumi Taniwaki; Masami Hirano; Yasuo Morishima; Ryuzo Ueda; Hiroshi Shiku; Shigeo Nakamura
Journal:  Haematologica       Date:  2008-06-12       Impact factor: 9.941

10.  Correlations of chromosome abnormalities with histologic and immunologic characteristics in 49 patients from Akita, Japan with non-Hodgkin lymphoma.

Authors:  K Hashimoto; I Miura; A Chyubachi; M Saito; A B Miura
Journal:  Cancer Genet Cytogenet       Date:  1995-05
View more
  6 in total

Review 1.  Primary hepatosplenic CD5-positive diffuse large B-cell lymphoma: a case report with literature review.

Authors:  Xiaohui Zhang; Manhua Sun; Ling Zhang; Haipeng Shao
Journal:  Int J Clin Exp Pathol       Date:  2013-04-15

2.  Subtle bone marrow involvement by large B-cell lymphoma with pronormoblast-like morphology and prominent but not exclusive sinusoidal distribution.

Authors:  Christine G Roth; Kaaren K Reichard
Journal:  Am J Blood Res       Date:  2012-04-15

3.  Splenic non-Hodgkin's lymphoma without organomegaly: occult presentation with fatal course and post-mortem diagnosis.

Authors:  Russell P Gollard; Diana Garcia
Journal:  Rare Tumors       Date:  2010-03-31

4.  Primary splenic lymphoma: a case report.

Authors:  Abhay K Kattepur; S Rohith; B S Shivaswamy; Rajashekara Babu; C S Santhosh
Journal:  Indian J Surg Oncol       Date:  2013-06-21

5.  Fever and arthralgia as the initial symptoms of primary bone marrow diffuse large B-cell lymphoma: A case report.

Authors:  Saisai Ren; Yanling Tao; L U Jia; Panpan Cheng; Jilei Zhang; Hao Zhang
Journal:  Oncol Lett       Date:  2016-04-04       Impact factor: 2.967

Review 6.  Low-Grade Primary Splenic CD10-Positive Small B-Cell Lymphoma/Follicular Lymphoma.

Authors:  Rami Abdulbaki; Parastou Tizro; Victor E Nava; Maria Gomes da Silva; João L Ascensão
Journal:  Curr Oncol       Date:  2021-11-18       Impact factor: 3.677

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.